Exane Asset Management Acquires New Holdings in Synopsys, Inc. $SNPS

Exane Asset Management bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 8,232 shares of the semiconductor company’s stock, valued at approximately $4,062,000. Synopsys accounts for about 1.5% of Exane Asset Management’s holdings, making the stock its 12th biggest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Synopsys by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock worth $7,721,363,000 after purchasing an additional 231,014 shares during the period. State Street Corp lifted its stake in Synopsys by 1.2% during the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after purchasing an additional 85,662 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Synopsys by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after buying an additional 51,043 shares during the period. Ameriprise Financial Inc. grew its stake in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after buying an additional 585,494 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in shares of Synopsys by 10.9% in the 2nd quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after buying an additional 187,790 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SNPS has been the subject of a number of research analyst reports. Citigroup assumed coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price for the company. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Piper Sandler cut shares of Synopsys from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $602.00 to $520.00 in a research report on Tuesday, January 13th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and a consensus target price of $553.57.

Insider Buying and Selling

In other news, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is currently owned by company insiders.

Synopsys Stock Down 0.1%

Shares of Synopsys stock opened at $502.70 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a market capitalization of $96.18 billion, a P/E ratio of 62.92, a P/E/G ratio of 4.19 and a beta of 1.12. The company has a 50 day moving average of $471.61 and a 200 day moving average of $502.77.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period in the previous year, the company earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.